Providing safe medicines for children in Nigeria: The impediments and remedies

Annals of African Medicine

Volumn 9, Issue 4, 2010, Pages 203-212

  Oshikoya, K A ^a,b,c   Senbanjo, I O ^b  

^a LAGOS STATE UNIVERSITY   (Nigeria)

^b LAGOS STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^c Royal Derby Hospital   (United Kingdom)

Author keywords

Children; medicine; Nigeria; safe

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; DIETHYLENE GLYCOL; EXCIPIENT; PARACETAMOL; PROPYLENE GLYCOL; TROVAFLOXACIN; DRUG;

ACCESS TO INFORMATION; BRAIN DAMAGE; DEVELOPING COUNTRY; DRUG COST; DRUG FORMULATION; DRUG INDUSTRY; DRUG INFORMATION; DRUG QUALITY; DRUG RESEARCH; DRUG SAFETY; DRUG STORAGE; DRUG SURVEILLANCE PROGRAM; EVIDENCE BASED MEDICINE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH SURVEY; HEARING IMPAIRMENT; HUMAN; MALARIA; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL PRACTICE; MEDICATION ERROR; MEDICINE; NIGERIA; PARALYSIS; REVIEW; WORLD HEALTH ORGANIZATION; ADVERSE DRUG REACTION; CHILD; CLINICAL PHARMACOLOGY; CLINICAL PRACTICE; EDUCATION; PEDIATRICS; STANDARDS;

CHILD; DRUG INFORMATION SERVICES; EVIDENCE-BASED MEDICINE; HUMANS; NIGERIA; PEDIATRICS; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY, CLINICAL; PHYSICIAN'S PRACTICE PATTERNS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;

EID: 77958047570     PISSN: 15963519     EISSN: 09755764     Source Type: Journal    
DOI: 10.4103/1596-3519.70954     Document Type: Review

References (92)

1. Sweis D, Wong IC. Giving medicines to children: Understanding the parents' views. Pediatr Drugs 2004; 6:67-9.
2. The International Alliance for Better Medicines for Children: The Alliance Declaration. Available from: http:// www.ppag.org/en/art/?348 [last accessed on 2008 Jan].
3. WHO. Promoting safety of medicines. Geneva: WHO, 2007. Available from: http://www.who.int/medicines/ publications/essentialmedicines/Promotion-safe- med- childrens.pdf [last accessed on 2008 Jan].
4. WHO Make Medicines Child Size http:// www.who.int/childmedicines/en/ index.html, [last accessed on 2008 July].
5. Beggs SA, Cranswick NE, Reed MD. Improving drug use for children in the developing world. Arch Dis Child 2005;90:1091-3.
6. Fetuga B, Ogunlesi T, Adekanbi F, Olanrewaju D, Olowu A. Comparative analyses of childhood deaths in Sagamu, Nigeria: Implications for the fourth MDG. SAJCH 2007; 1:106-11.
7. Eke FU, Frank-Briggs A, Ottor J. Childhood mortality in Port Harcourt, Nigeria. Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology, 2001;2: Available from: http://www.geradts.com/anil/ij/vol-002-no-002/ papers/paper003.html [last accessed on 2008 Dec].
8. Nwolisa CE, Erinaugha EU, Ofoleta SI. Prescribing practices of doctors attending to under fives in a children's outpatient clinic in Owerri, Nigeria. J Trop Pediatr 2005;52:197-200.
9. Oshikoya KA, Chukwura HA, Ojo OI. Evaluation of outpatient paediatric drug prescriptions in a teaching hospital in Nigeria for rational prescribing. Paediatr Perinat Drug Ther 2006;7:183-8.
10. Oshikoya KA, Njokanma OF, Chukwura HA, Ojo OI. Adverse drug reactions in Nigerian children. Paediatr Perinat Drug Ther 2007;8:81-8.
11. Levin T. Families sue Pfzer on test of antibiotics. NY Times. Available from: http://www.mindfully.org/ Industry/Pfzer-Trovan-Nigerian-Suit.htm [last accessed on 2008 Dec].
12. Okuonghae HO, Igbogboja IS, Lawson JO, Nwana EJ. Diethylene glycol poisoning in Nigerian children. Ann Trop Paediatr 1992;12:235-8.
13. Uzendu M, Udoh F. Nigeria: Paracetamol kills 25 kids. Available from: http://www.allafrica.com/stories/ printable/200811260698.html [last accessed on 2008 Nov].
14. NAFDAC NIGERIA. Journey: Some administrative guidelines. Available from: http://www.nafdacnigera.org/ journey.html [last accessed on 2008 Oct].
15. Rosenberg W, Donald A. Evidence based medicine: An approach to clinical problem-solving. BMJ 1995;310: 1122-6.
16. Kleinke JD, Malone DC, Urick P. Shift toward evidence-based medicine: The role of community-based guidelines. J Manag Care Pharm 2005;11:S1-24.
17. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: What it is and what it isn't. BMJ 1996;312:71-2.
18. Bonati M, Pandolfni C. Pediatric clinical trials registry. CMAJ 2005;172:1159-60.
19. Murray CL, Lopez AD. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press; 1996.
20. Campbell H, Surry SA, Royle E. A review of randomised control trials published in archives of disease in childhood from 1982-96. Arch Dis Child 1998; 79: 192-7.
21. Nor Aripin KN, Sammons HM, Choonara I. Published paediatric randomised drug trials in developing countries, 1996-2002. Pediatr Drugs 2010; 12: 99-103.
22. Isaakidis P, Swingler GH, Pienaar E, Volmink J, Ioannidis J P. Relation between burden of disease and randomised evidence in sub-Saharan Africa: Survey of research. BMJ 2002;324:702.
23. Kale R. Health information for the developing world. Br Med J 1994;309:939-42.
24. McConnell H, Haile-Mariam T, Rangerajan S. The world health channel: An innovation for health and development. World Hosp Health Serv 2004; 40: 36-9.
25. Crawford BD. Open-access publishing: Where is the value? Lancet 2003;362:1578-80.
26. Katikireddi SV. HINARI: Bridging the global information divide. Br Med J 2004;328:1190-3.
27. Aroson B. Improving online access to medical information for low-income countries. N Engl J Med 2004;350:966-8.
28. Smith R, Williamson A. BMJ journals free to the developing world. Br Med J 2002;324:380.
29. International Network for the Availability Scientific Publications. INASP infobrief 6. Journal Access Programmes in African University Libraries 2005. http://www.inasp.info/uploaded/documents/INASP%20 infobrief%206-web.pdf [last accessed on 2009 Aug].
30. Falkenberg T, Tomson G. The World Bank and pharmaceuticals. Health Policy Plan 2000;15:52-8.
31. Akande TM, Aderibigbe SA. Infuence of drug promotion on prescribing habits of doctors in a teaching hospital. Afr J Med Med Sci 2007;36:207-11.
32. Oshikoya KA, Senbanjo IO, Soipe A. Adequacy of pharmacological information provided in pharmaceutical drug advertisements in African medical journals. Pharm Pract 2009;7:100-7.
33. Pediatric Drugs. The offcial journal of the International Alliance for Better Medicine for Children, Pediatric Drugs is dedicated to improving the effective and safe use of drugs in pediatrics. Available from: http://www. ovid.com/site/catalog/Journal/293.pdf [last accessed on 2009 Aug].
34. Journal of Pharmacy and Pharmacology. An internationally recognised research publishing multidisciplinary research on the latest development in the pharmaceutical sciences. Available from: http://www.pharmpress. com/shop/editorial/docs/JPP-2009-factsheet.pdf [last accessed on 2009 Aug].
35. Tumwikirize WA, Ogwal-Okeng JW, Vernby A, Anokbonggo WW, Gustafsson LL, Lundborg CS. Access to up-to-date drug information in developing countries continues to pose problems: The case of Uganda. Pharmacoepidemiol Drug Saf 2007;16:1177-9.
36. Anderson M, Choonara I, Ito S, Koren G, Reider M. Paediatric clinical pharmacology training programmes in Canada and UK: A comparison. Paediatr Perinat Drug Ther 2007;8:26-30.
37. Choonara I, Dewit O, Harrop E, Haworth S, Helms P, Kanabar D, et al. Training in paediatric clinical pharmacology in the UK. Br J Clin Pharmacol 2004;58: 217-8.
38. Bonati M, Breitkreutz J, Choonara I, Hoppu K, Jacqz-Aigrain E, Langhendries J, et al. Paediatric clinical pharmacology in Europe. Paediatr Perinat Drug Ther 2006;7:134-7.
39. Bonati M, Choonara I, Hoppu K, Pons G, Seyberth H. Closing the gap in drug therapy. Lancet 1999;353:1625.
40. Loebstein R, Addis A, Ho E, Andreou R, Sage S, Donnenfeld AE, et al. Pregnancy outcome following gestational exposure to fuoroquinolones: A multicentre prospective controlled study. Antimcrob Agents Chemother 1998;42:1336-9.
41. McIntyre J, Robertson S, Norris E, Appleton R, Whitehouse WP, Phillips B, et al. Safety and effcacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: A randomised controlled trial. Lancet 2005;366:205-10.
42. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: A systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001;52:77-83.
43. Sammons HM, Gray C, Hudson H, Cherrill J, Choonara I. Safety in paediatric clinical trials: A 7 year reviews. Acta Paediatr 2008;97:474-7.
44. Oshikoya KA, Senbanjo IO, Amole OO. Interns' knowledge of clinical pharmacology and therapeutics after undergraduate and on-going internship training in Nigeria: A pilot study. BMC Med Educ 2009;9:50.
45. Oshikoya KA, Bello JA, Ayorinde EO. Prescribing knowledge and skills of fnal year medical students in Nigeria. Indian J Pharmacol 2008;40:251-5.
46. Oshikoya KA, Senbanjo IO, Soipe A. Ability of medical students to calculate drug doses in children after their paediatric attachment. Pharm Pract 2008; 6: 191-6.
47. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events: Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34.
48. Lesar TS, Briceland LL, Stein DS. Factors related to errors in medication prescribing. JAMA 1997;277:312-7.
49. Ohaju-Obodo JO, Isah AO, Mabadeje AF. Prescribing patterns of clinicians in private health institutions in Edo and Delta States of Nigeria. Nig Q J Hosp Med 1998;8:91-4.
50. Odusanya OO, Oyediran MA. Rational drug use at the primary health care centres in Lagos, Nigeria. Nig Q J Hosp Med 2000;10:4-7.
51. Oshikoya KA, Senbanjo IO. Cefxime-induced dystonia and hypothermia in a 12-year old boy: A need for safe prescribing. Int J Pharmacol 2008;4:233-6.
52. Quick JD, Hogerzeil HV, Velasquez G, Rago L. Twenty-fve years of essential medicines. Bull World Health Organ 2002;80:913-4.
53. Oshikoya KA, Senbanjo IO, Njokanma OF. Parental reporting of suspected adverse drug reactions in children in Lagos, Nigeria. Arch Dis Child 2009;94:469-73.
54. th Revision, Lagos, 2003.
55. nd ed, March 2010. Available from: http://www.who. int/medicines/publications/ essentialmedicines/ Updated-second-children-list-en.pdf [last accessed on 2010 May].
56. Oshikoya KA, Njokanma OF, Bello JA, Ayorinde EO. The use of prescribed and non-prescribed drugs in infants in Lagos, Nigeria. J Med Sci 2008;8:111-7.
57. WHO. Selected topics in health reform and drug fnancing. Geneva: WHO, 1998. Available from: http:// www.who.int/medicines/library/dap/who-dap98-3/ who-dap-98-3.pdf [last accessed on 2008 Apr].
58. Choonara I, Conroy S. Unlicensed and off-label drug use in children: Implications for safety. Drug Saf 2002;25:1-5.
59. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed drug use on paediatric wards. BMJ 1998;316:343-5.
60. Conroy S, McIntyre J, Choonara I. Unlicensed and off-label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F142-4.
61. McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off-label prescribing of drugs in general practice. Arch Dis Child 2000;83:498-501.
62. Tan E, Cranswick NE, Rayner CR, Chapman CB. Dosing information for paediatric patients: Are they really "therapeutic orphans"? Med J Aust 2003;179:195-8.
63. Oshikoya KA. Antimalarial prescription for children presenting with uncomplicated malaria to a teaching hospital in Nigeria after the change of national guidelines for malaria treatment. World J Med Sci 2007;2:49-53.
64. Choonara I. WHO wants safer medicines for children. Arch Dis Child 2008;93:456-7.
65. Anabwani GM. Drug development: A new perspective from Africa. Paediatr Perinat Drug Ther 2002;5:4-11.
66. Choonara I, Reider MJ. Drug toxicity and adverse reactions in children: A brief historical review. Peadiatr Perinat Drug Ther 2002;5:12-8.
67. Oshikoya KA, Njokanma OF, Bello JA, Ayorinde EO. Family self-medication for children in an urban area of Nigeria. Paediatr Perinat Drug Ther 2007;8:124-30.
68. th ed. Ohio: Lexi-Comp Inc.;2004.
69. Edwards I, Olsson S. WHO: Global monitoring. In: Mann RD, Andrew E, editors. Pharmacovigilance. Chichester: Blackwell Publishing: Oxford; 2003. p. 169-82.
70. Ahmad SR. Adverse drug event monitoring at the food and drug administration. J Gen Intern Med 2003;285: 437-43.
71. Lexchin J. Is there a role for spontaneous reporting of adverse drug reactions? CMAJ 2006;174:191-2.
72. Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol 2009;9:14.
73. Luo X, Doherty J, Cappelleri JC, Frush K. Role of pharmacoepidemiology in evaluating prescription drug safety in pediatrics. Curr Med Res Opin 2007;23: 2607-15.
74. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367:1747-57.
75. National Agency for Food and Drug Administration and Control. Drugs-general guidelines. Available from: http://www.nafdacnigeria.org/drugs. html [last accessed on 2008 May].
76. Ibekwe J. Artemesinim resistant malaria on the horizon (editorial). Int J Med Sci 2009;1:1-2.
77. Bonati M. Once again, children are the main victims of fake drugs. Arch Dis Child 2009;94:468.
78. World Health Organization. Combating counterfeit drugs: A concept paper for effective international collaboration. WHO (Health Technology and Pharmaceuticals) 2005. Available from: http://www.who.int/medicines/services/ counterfeit/CombatingCounterfeitDrugs-Conceptpaper. pdf [last accessed on 2009 Nov].
79. Yusuff KB, Yusuf A. Advertising of OTC products in a Nigerian urban setting: Content analysis for indications, targets, and advertising appeal. J Am Pharm Assoc 2009;49:432-5.
80. Vitry A. Is Australia free from direct-to-customer advertising? Australian Prescriber (Aust Prescr). 2004; 27:4-6.
81. Oshikoya KA, Senbanjo IO, Njokanma OF. Self-medication for infants with colic in Lagos, Nigeria. BMC Pediatr 2009;9:9.
82. Oshikoya KA, Senbanjo IO, Njokanma OF, Soipe A. Use of complementary and alternative medicines for children with chronic health conditions in Lagos, Nigeria. BMC Complement Altern Med 2008;8:66.
83. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: A systematic review. Drugs 2001; 61:2163-75.
84. Adesina SK. Traditional medical care in Nigeria. Available from: http://www.onlinenigeria.com/links/ LinksReadPrint.asp?blurb=574 [last accessed on 2009 Mar].
85. Obi E, Agbasi PU, Ezejiofor NA, Maduagwuna C, Orisakwe OE. Safety warnings and frst aid instructions on Nigerian traditional herbal remedies: Are they adequate. World J Med Sci 2006;1:108-11.
86. Yoon EY, Freed GL. The need for creation of comprehensive pediatric research network. Pediatr Drug 2008;10:279-80.
87. General Medical Council. Tomorrow's doctors. London: General Medical Council; 2002. Available from: http:// www.gmc-uk.org/med-ed/tomdoc.htm [last accessed on 2009 Nov].
88. Khan KS, Dwarakanath LS, Pakkal M, Brace V, Awonuga A. Postgraduate journal club as a means of promoting evidence-based obstetrics and gynaecology. J Obstet Gynaecol 1999;19:231-4.
89. Yew KS, Reid A. Teaching evidence-based medicine skills: An exploratory study of residency graduates' practice habits. Fam Med 2008;40:24-31.
90. The Cochrane Library. Cochrane Central Register of Controlled Trials. Available from http://www.mrw. interscience.wiley.com/cochrane/cochrane- clcentral- articles-fs.html [last accessed on 2009 Nov].
91. Darmanin Ellul R, Cordina M, Buhagiar A, Fenech A, Mifsud J. Knowledge and sources of information about medicines among adolescents in Malta. Pharm Pract 2008;6:176-86.
92. MHRA. Risks and benefts of medicines and medical devices: Perceptions, communication and regulation-overview of IPSoS MORI Research Conducted for The Medicines and Healthcare Products Regulatory Agency (MHRA). Available from: www.mhra.gov.uk/home/ idcplg?IdcService=GET-FILE.Latest [last accessed on 2010 May].